excited about monotherapies, page-11

First 11 Last

Share
Profile

Follow
rae915

4,627 Posts.

166

31/01/15

03:41

Post #: 14672890
Share

Originally posted by kippax ↑

Hi All

The relevant text as follows:

From ANNEX 1 WHO briefing sessions.
Item 2 Implications for industry of the WHO Guidelines for the treatment of malaria.

The WHO Guidelines recommend parasitological (microscopy or RDT ) confirmation before treatment, WITH THE ONLY EXCEPTIONS FOR CHILDREN UNDER 5 YEARS OF AGE in areas of high transmission, where treatment in this group should be based on clinical diagnosis, and for suspected SEVERE malaria if parasitilogical conformation is not immediately possible.

a) uncomplicated P.falciparum malaria
b) P.vivax malaria

c) severe P.falciparum malaria
Quinine or an artemisinin derivative (artesunate, artemether or artemoil )by i.v.. or i.m. route are recommended for treatment of severe malaria. This must be followe by a full treatmment course of an effective ACT as soon as patients are able to tolerate oral medication. Artemisinin derivatives administered through the rectal route are recommended only for pre-referral treatment of severe malaria.

The implications for the pharmaceutical industry of the new WHO malaria treatment guidelines are ro reorient production and marketing activities to ensure that:
1) Artemisinin monotherapies are not used for treatment of uncomplicated malaria, whethr in the form of tablets, oral suspensions, supposittories, recto-capsules or vials for parenteral administration.
2)Artemisinin monotherapies in rectal formulations are used only for pre-referral treatment of severe malaria.
3)Artemisinin monotherapies in parenteral formulations are only used for the management of severe malaria.

NOW isn't that fanatastic that ArTiMist ticks all these boxess

Target treatmet for children under 5 years old.
Treatment for severe malaria
Pre-referral treatment.
ArTiMist treatment beats the socks off Quinine (the recommended treatment)
Monotherapies are permitted for pre-referral treatment.

That is why I am so excited about meetings in March.

kippax

Testing continuing with SUD 003 after successful lodging of patent....someone has to do it

Expand

your testing must be the reason you are so excited.
Time to buy before the rocket takes off ???
Could be the afterburners are getting warmed up????

GLTA

SUD Price at posting: 4.1¢ Sentiment: None Disclosure: Not Held
3 Upvote

0 Great analysis

Reply

Top Stories

GRE

Greentech finds lithium trend across 5.5 km at WA's Kobe South

LGM

Legacy shares jump on discovery of multiple epithermal veins at Bauloora JV

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

PYC

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

AW1

American West does it again at Storm with visually identified thick copper hits at Cyclone, Lightning Ridge

There are more pages in this discussion • 1 more message in this thread...

First 11 Last

Add ALA (ASX) to my watchlist

(20min delay)
Last 14.0¢		Change 0.000(0.00%)		Mkt cap ! $147.1M

Open	High	Low	Value	Volume
14.5¢	14.5¢	14.0¢	$82.82K	582.9K

Buyers (Bids)

No.	Vol.	Price($)
12	514820	14.0¢

Sellers (Offers)

Price($)	Vol.	No.
14.5¢	431957	7

View Market Depth

No.	Vol.	Price($)
12	514820	0.140
9	330868	0.135
10	616104	0.130
8	691879	0.125
11	791339	0.120

Price($)	Vol.	No.
0.145	431957	7
0.150	636710	6
0.155	88709	3
0.160	1471739	5
0.165	322812	1

Last trade - 16.10pm 10/07/2024 (20 minute delay)

ALA (ASX) Chart

excited about monotherapies, page-11

Greentech finds lithium trend across 5.5 km at WA's Kobe South

Legacy shares jump on discovery of multiple epithermal veins at Bauloora JV

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

American West does it again at Storm with visually identified thick copper hits at Cyclone, Lightning Ridge

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

excited about monotherapies, page-11

Top Stories

Greentech finds lithium trend across 5.5 km at WA's Kobe South

Legacy shares jump on discovery of multiple epithermal veins at Bauloora JV

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

American West does it again at Storm with visually identified thick copper hits at Cyclone, Lightning Ridge

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News